Related Experiment Videos
Thromboprophylaxis in orthopedic surgery.
1Shiley Center for Orthopaedic Research and Education at Scripps Clinic, La Jolla, California, USA.
American Journal of Orthopedics (Belle Mead, N.J.)
|July 19, 2006
Summary
Orthopedic surgery patients face high risks of deep vein thrombosis (DVT) and pulmonary embolism. Current guidelines recommend thromboprophylaxis using anticoagulants or mechanical methods to prevent these serious complications.
Area of Science:
- Orthopedic Surgery
- Cardiovascular Medicine
- Pharmacology
Background:
- Over 2 million major orthopedic surgeries are performed annually, with numbers projected to increase due to an aging population.
- Patients undergoing orthopedic surgery have a significantly elevated risk of developing deep vein thrombosis (DVT) and pulmonary embolism (PE).
Purpose of the Study:
- To review current guidelines and effective methods for thromboprophylaxis in high-risk orthopedic surgery patients.
- To outline the goals of preventing DVT, PE, and associated long-term complications.
Main Methods:
- Review of American College of Chest Physicians guidelines.
- Analysis of pharmacological (low-molecular-weight heparin, fondaparinux, warfarin, unfractionated heparin) and mechanical prophylaxis options.
Main Results:
- Thromboprophylaxis is recommended for high-risk orthopedic surgery patients.
- Various anticoagulant and mechanical methods are effective in preventing DVT and PE.
Conclusions:
- Effective thromboprophylaxis is crucial for reducing DVT and PE incidence in orthopedic surgery.
- Treatment aims to prevent proximal/distal DVT, pulmonary death, chronic pulmonary hypertension, and postthrombotic syndrome.